z-logo
open-access-imgOpen Access
Resistance to poly ADP-ribose polymerase inhibitors and its clinical implications
Author(s) -
Amit Verma
Publication year - 2022
Publication title -
international journal of molecular and immuno oncology
Language(s) - English
Resource type - Journals
eISSN - 2836-3779
pISSN - 2456-3994
DOI - 10.25259/ijmio_12_2022
Subject(s) - poly adp ribose polymerase , parp inhibitor , genome instability , polymerase , synthetic lethality , breast cancer , homologous recombination , cancer research , olaparib , prostate cancer , dna repair , biology , medicine , cancer , gene , dna damage , dna , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom